《半日总结》恒指跌18点 比亚迪受压 龙湖挫11%
小米(01810.HK)停牌及传出折让9%配股，与及多间企业宣布发新股或配股，影响大市气氛，港股早市下跌。恒指高开102点报26,670点後向下，上午中段曾跌188点见26,379点，中午前跌幅收窄，半日跌18点或0.1%，报26,548点；国指跌67点或0.6%，报10,591点；恒生科技指数跌85点或1.1%，报7,899点。大市半日成交总额826.44亿元，沪、深港通南下交易半日录得净流入金额分别为13.61亿及3.13亿元人民币。
科技股普遍下跌。腾讯(00700.HK)及阿里巴巴(09988.HK)各跌0.7%及0.6%，分别报574元及255.6元，美团(03690.HK)跌4.6%报276元，京东(09618.HK)及网易(09999.HK)各跌2.9%及2.5%。恒腾(00136.HK)、阅文(00772.HK)、平安好医生(01833.HK)及众安在线(06060.HK)各跌2.8%至3.5%，易鑫(02858.HK)及金蝶(00268.HK)各跌4.3%及4.9%。心动(02400.HK)逆升2.4%。手机部件股舜宇(02382.HK)跌2.1%，晶片股中芯(00981.HK)及华虹半导体(01347.HK)各升3.5%及2.6%。
汽车股受压，比亚迪(01211.HK)向中证监申请增发H股，比亚迪跌8.4%报171.8元。吉利(00175.HK)跌5.1%，广汽(02238.HK)及长汽(02333.HK)各跌2.4%及3.7%。内需股个别发展，呷哺呷哺(00520.HK)获高盛唱好，股价升7.4%。润啤(00291.HK)升3.1%，国美(00493.HK)跌2.2%。体育用品股李宁(02331.HK)及滔搏(06110.HK)各跌3.1%及3.7%。
医药股走弱，威高(01066.HK)及康方生物(09926.HK)各跌5.1%及4.3%，中生制药(01177.HK)、丽珠医药(01513.HK)及信达生物(01801.HK)各跌3%至3.6%，药明生物(02269.HK)及三生制药(01530.HK)各跌2.4%。
内房股龙湖(00960.HK)先旧後新配股净筹23亿元，控股股东同时配股减持，龙湖股价挫11.2%报45.1元。世茂(00813.HK)及恒大(03333.HK)各跌2.1%及1.7%。恒大分拆物业管理分支恒大物业(06666.HK)首日挂牌，半日收8.72元，较上市价8.8元低0.9%。
金融股方面，汇控(00005.HK)升3.9%报42.6元，渣打(02888.HK)升4.3%报49.3元。内银股工行(01398.HK)及邮储行(01658.HK)各回吐1%及1.3%，中国平安(02318.HK)升0.8%报95.1元。友邦(01299.HK)跌0.4%报87.85元，港交所(00388.HK)跌1.3%报381元。
光伏股保利协鑫(03800.HK)升7.8%报0.97元，半日成交逾7亿元。信义光能(00968.HK)则跌5.1%报13.42元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
